Skip to main content
. 2023 Apr 5;13:1053248. doi: 10.3389/fonc.2023.1053248

Table 2.

Demographics and Clinical Characteristics by age group.

Variable Age, years P value
0—4 5—9 10—14 15—19
Gender 0.46
 Male 40 10 31 62
 Female 35 16 30 77
Race 0.6
 White 62 17 46 115
 Black 7 7 9 18
 AI 0 0 1 1
 API 5 2 4 4
Primary site 0.65
 Upper lobe 25 6 16 34
 Middle lobe 5 3 4 15
 Lower lobe 24 6 18 52
 Overlapping 4 2 3 7
 T and B 6 6 9 19
 NOS 11 3 11 12
Laterality 0.37
 Right 36 12 30 77
 Left 37 11 27 53
 Bilaterality 1 3 2 8
 NOS 1 0 2 1
Histology <0.01
 Carcinoid tumor 1 1 23 64
 MEC 3 11 9 14
 Adenocarcinoma 2 5 12 12
 SCC 0 1 1 10
 NET 0 0 2 14
 Pulmonary blastoma 59 3 3 2
 Atypical carcinoma 0 0 1 6
 other 10 5 10 17
Grade 0.02
 I 4 7 11 31
 II 2 3 10 15
 III 3 2 4 9
 IV 4 0 2 4
 Unknown 62 14 34 80
Surgery 0.03
 Yes 69 21 48 104
 No 6 5 13 35
TNM stage <0.01
 I 4 10 21 30
 II 1 1 5 13
 III 1 3 3 17
 IV 1 2 7 23
 Unknown 68 10 25 56
Radiotherapy 0.12
 yes 6 0 4 18
 no 69 26 57 121
Chemotherapy <0.01
 yes 50 5 13 44
 no/unknown 25 21 48 95

AI, American Indian/Alaska Native; API, Asian or Pacific Islander; T and B, Trachea and Main bronchus; Overlapping, Overlapping lesion of lung; MEC, mucoepidermoid carcinoma; SCC, squamous cell carcinoma; NET, neuroendocrine tumor.